An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
Clinical trial NCT03414983 · COMPLETED
Trial details
- NCT number
- NCT03414983
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2021-02-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.